CD8A and neoplasm: In another study by this group, treatment of tumor bearing mice with α-GalCer-loaded DCs decreased metastatic disease and enhanced survival that was associated with a reduction in MDSC, followed by the induction of antitumor responses by NKT cells and CD8+ T cells [72].